12 Health Care Stocks Moving In Tuesday's After-Market Session
Portfolio Pulse from Benzinga Insights
In Tuesday's after-market session, several healthcare stocks experienced significant price movements. Protagenic Therapeutics, Talphera, Context Therapeutics, Fortrea Holdings, Genelux, and ENDRA Life Sciences saw gains, while TELA Bio, Ensysce Biosciences, Genprex, Allakos, Sensei Biotherapeutics, and TuHURA Biosciences experienced declines.
October 22, 2024 | 8:31 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Context Therapeutics shares rose 8.49% to $2.17, reflecting positive after-market sentiment.
The increase in share price suggests positive investor sentiment, likely resulting in short-term gains.
CONFIDENCE 85
IMPORTANCE 65
RELEVANCE 100
POSITIVE IMPACT
Fortrea Holdings shares rose 6.68% to $18.99, indicating positive after-market activity.
The price increase suggests positive sentiment, potentially leading to short-term gains.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Genelux stock rose 6.15% to $2.76, showing positive after-market movement.
The rise in stock price indicates positive sentiment, likely resulting in short-term gains.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 100
POSITIVE IMPACT
ENDRA Life Sciences stock rose 5.26% to $0.44, reflecting positive after-market sentiment.
The increase in share price suggests positive investor sentiment, likely leading to short-term gains.
CONFIDENCE 80
IMPORTANCE 55
RELEVANCE 100
POSITIVE IMPACT
Protagenic Therapeutics stock rose 21.4% to $0.78, indicating strong after-market interest.
The significant price increase suggests positive sentiment or news, likely leading to short-term gains.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Talphera shares increased by 11.7% to $1.05, showing positive after-market momentum.
The rise in share price indicates investor optimism, potentially leading to further short-term gains.
CONFIDENCE 85
IMPORTANCE 60
RELEVANCE 100
NEGATIVE IMPACT
Allakos stock declined by 6.72% to $1.25, indicating negative after-market sentiment.
The decline in share price indicates negative sentiment, likely resulting in short-term losses.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 100
NEGATIVE IMPACT
Ensysce Biosciences shares declined by 11.45% to $0.48, reflecting negative after-market sentiment.
The decline in share price indicates negative sentiment, likely resulting in short-term losses.
CONFIDENCE 85
IMPORTANCE 65
RELEVANCE 100
NEGATIVE IMPACT
Genprex stock decreased by 10.59% to $3.21, showing negative after-market movement.
The decrease in stock price suggests negative sentiment, likely leading to short-term losses.
CONFIDENCE 85
IMPORTANCE 60
RELEVANCE 100
NEGATIVE IMPACT
TuHURA Biosciences stock decreased by 6.67% to $4.9, showing negative after-market movement.
The decline in stock price indicates negative sentiment, likely resulting in short-term losses.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 100
NEGATIVE IMPACT
Sensei Biotherapeutics shares declined by 6.71% to $0.58, reflecting negative after-market sentiment.
The decrease in share price suggests negative sentiment, likely leading to short-term losses.
CONFIDENCE 80
IMPORTANCE 55
RELEVANCE 100
NEGATIVE IMPACT
TELA Bio shares declined by 15.7% to $2.1, indicating negative after-market sentiment.
The significant decline suggests negative sentiment or news, likely leading to short-term losses.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100